Levomilnacipran
Country:
United States
Year:
subscribe
Notify me when a new related topic is posted
Share page
more »
Edit
Add to rankings
Information

Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo- enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI).

Add your opinion:
Preview:
(mouse over or touch to update)
Item ID:
OK
choose profile
Add your opinion
Add item to new rankings
or
create new ranking

Topics

Active
New
Popular
all
today
week
month
year
No custom topics related to Levomilnacipran.
Create new topic.